Point-of-care hepatitis C testing and treatment strategy for people attending harm reduction and addiction centres for hepatitis C elimination

被引:19
作者
Forns, Xavier [1 ,2 ]
Colom, Joan [3 ]
Garcia-Retortillo, Montse [4 ]
Carles Quer, Joan [5 ]
Lens, Sabela [1 ,2 ]
Martro, Elisa [6 ,7 ]
Dominguez-Hernandez, Raquel [8 ]
Angel Casado, Miguel [8 ]
Buti, Maria [2 ,9 ]
机构
[1] Univ Barcelona, Hosp Clin Barcelona, Liver Unit, IDIBAPS, Barcelona, Spain
[2] Inst Carlos III, CIBERehd, Barcelona, Spain
[3] Agcy Publ Hlth Catalonia, Programme Prevent Control & Treatment HIV STIs &, Programme Subst Abuse, Barcelona, Spain
[4] Hosp Mar, Dept Gastroenterol, Liver Sect, Barcelona, Spain
[5] Univ Hosp Joan XXIII, Gastroenterol Dept, Tarragona, Spain
[6] Hosp Badalona Germans Trias & Pujol, Inst Invest Ciencies Salut Germans Trias & Pujol, Microbiol Dept, Lab Clin Metropolitana Nord, Badalona, Spain
[7] Inst Salud Carlos III, Biomed Res Networking Ctr Epidemiol & Publ Hlth C, Madrid, Spain
[8] Pharmacoecon & Amp Outcomes Res Iberia PORIB, Madrid, Spain
[9] Hosp Univ Vall dHebron, Internal Med Dept, Liver Unit, Barcelona, Spain
关键词
addiction centres; cascade of care; drug users; harm reduction services; hepatitis C virus; linkage-to-care; test and treat;
D O I
10.1111/jvh.13634
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
According to WHO goals, the elimination of Hepatitis C Virus (HCV) by 2030 requires enhancing and simplifying HCV testing. Our aim was to create a model to assess and compare different strategies for HCV testing, linkage to care and treatment among people who access harm reduction centres (HRC) and Addiction Centres in Catalonia. A decision tree model was designed to evaluate two strategies: Hepatitis C Point-of-care (POC) "test and treat", at the community versus standard-of-care (SOC), in which HCV testing was performed at community and therapy at the hospital. Both strategies were assessed separately in HRCs (6,878 users) and Addiction Centres (13,778 users). with a time horizon of 18 months. Healthcare outcomes were HCV testing, linkage to care, treatment outcomes and reinfection rate. HCV testing was performed in 3,178 (46%) of the HRC users. Compared with SOC, POC increased access to treatment by 57% (63% vs. 6%). SVR rates were 64% in POC vs. 23% in SOC. Reinfection rates were 21% with POC compared to 24% with SOC. With POC, losses to follow-up were reduced by 41%. In the Addiction Centres, 12,566 users (91%) were screened using the two strategies. Compared to the SOC, POC increased access to treatment and linkage to care by 19% along with SVR at the same rate. Reinfection rates decreased by 6%. Thus, the implementation of a POC "test and treat" strategy at HRCs and Addiction Centres has shown to be an effective public health strategy to help eliminating HCV in accordance with WHO goal.
引用
收藏
页码:227 / 230
页数:4
相关论文
共 50 条
  • [21] Towards the elimination of hepatitis C: implementation of reflex testing in Andalusia
    de la Paz Casas, Maria
    Garcia, Fernando
    Freyre-Carrillo, Carolina
    Montiel, Natalia
    de la Iglesia, Alberto
    Viciana, Isabel
    Dominguez, Ana
    Guillot, Vicente
    Munoz, Aurora
    Cantudo, Purificacion
    Franco-Alvarez, Francisco
    Antonio Reguera, Juan
    Angustias Romera, Maria
    Cabezas, Teresa
    Vargas, Julio
    Ramirez-Arcos, Mercedes
    Guerrero, Inmaculada
    Garcia-Navarrete, Africa
    Jesus Perez-Santos, Maria
    Clavijo, Encarnacion
    Roldan, Carolina
    Guzman, Antonio
    Palanca, Matilde
    Torres, Eva
    del Carmen Serrano, Maria
    del Carmen Lozano, Maria
    Becerril, Berta
    Luzon, Pilar
    Angeles Galan, Maria
    Carlos Alados, Juan
    Garcia, Federico
    [J]. REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2020, 112 (07) : 515 - 519
  • [22] Disparities in hepatitis C care across Canadian provincial prisons: Implications for hepatitis C micro-elimination
    Kronfli, Nadine
    Dussault, Camille
    Bartlett, Sofia
    Fuchs, Dennaye
    Kaita, Kelly
    Harland, Kate
    Martin, Brandi
    Whitten-Nagle, Cindy
    Cox, Joseph
    [J]. CANADIAN LIVER JOURNAL, 2021, 4 (03): : 292 - 310
  • [23] Hepatitis C testing and re-testing among people attending sexual health services in Australia, and hepatitis C incidence among people with human immunodeficiency virus: analysis of national sentinel surveillance data
    David C. Boettiger
    Matthew G. Law
    Gregory J. Dore
    Rebecca Guy
    Denton Callander
    Basil Donovan
    Catherine C. O’Connor
    Christopher K. Fairley
    Margaret Hellard
    Gail Matthews
    [J]. BMC Infectious Diseases, 17
  • [24] Hepatitis C testing and re-testing among people attending sexual health services in Australia, and hepatitis C incidence among people with human immunodeficiency virus: analysis of national sentinel surveillance data
    Boettiger, David C.
    Law, Matthew G.
    Dore, Gregory J.
    Guy, Rebecca
    Callander, Denton
    Donovan, Basil
    O'Connor, Catherine C.
    Fairley, Christopher K.
    Hellard, Margaret
    Matthews, Gail
    [J]. BMC INFECTIOUS DISEASES, 2017, 17
  • [25] An overview of forensic drug testing methods and their suitability for harm reduction point-of-care services
    Lane Harper
    Jeff Powell
    Em M. Pijl
    [J]. Harm Reduction Journal, 14
  • [26] An overview of forensic drug testing methods and their suitability for harm reduction point-of-care services
    Harper, Lane
    Powell, Jeff
    Pijl, Em M.
    [J]. HARM REDUCTION JOURNAL, 2017, 14
  • [27] Hepatitis C diagnosis and treatment in people who use drugs: mind the gap in the linkage to care
    Taibi, C.
    Luzzitelli, I
    Comandini, U. Visco
    Girardi, E.
    Monacelli, G.
    Rapisarda, L. M.
    Garbuglia, A. R.
    Minosse, C.
    Guarrasi, V
    Vincenzi, L.
    Iacomi, F.
    D'Offizi, G.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (19) : 5913 - 5921
  • [28] The hepatitis C care cascade among people who inject drugs accessing harm reduction services in Catalonia: Major gaps for migrants
    Folch, Cinta
    Saludes, Veronica
    Reyes-Urena, Juliana
    Antuori, Adrian
    Ibanez, Nuria
    Majo, Xavier
    Colom, Joan
    Matas, Lurdes
    Casabona, Jordi
    Martro, Elisa
    [J]. INTERNATIONAL JOURNAL OF DRUG POLICY, 2021, 90
  • [29] Integrating hepatitis C testing and treatment into routine HIV care in Cameroon is feasible
    Kowo, Mathurin Pierre
    Coyer, Liza
    Sini, Victor
    Kafack, Carole Assontsa
    Metomo, Gabriella Yelheen
    Wafeu, Guy S.
    Njouom, Richard
    Boers, Alexander
    Coutinho, Roel
    Njoya, Oudou
    Kouanfack, Charles
    HEPC project team
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2025, 28 (02)
  • [30] Hepatitis C virus treatment as prevention in people who inject drugs: testing the evidence
    Hickman, Matthew
    De Angelis, Daniela
    Vickerman, Peter
    Hutchinson, Sharon
    Martin, Natasha Kaleta
    [J]. CURRENT OPINION IN INFECTIOUS DISEASES, 2015, 28 (06) : 576 - 582